Cutaneous immunological activation elicited by a low-fluence pulsed dye laser

Summary Background  Three years ago, the nonablative wrinkle reduction laser (a 585‐nm laser, Chromogenex V3; Chromogenex Light Technologies, Llanelli, U.K.) was developed, and there have already been several reports about its clinical effectiveness. The Chromogenex V3 laser has also been reported t...

Full description

Saved in:
Bibliographic Details
Published in:British journal of dermatology (1951) Vol. 153; no. s2; pp. 57 - 62
Main Authors: Omi, T., Kawana, S., Sato, S., Takezaki, S., Honda, M., Igarashi, T., Hankins, R.W., Bjerring, P., Thestrup-Pedersen, K.
Format: Journal Article
Language:English
Published: Oxford, UK Blackwell Publishing Ltd 01-12-2005
Oxford University Press
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Background  Three years ago, the nonablative wrinkle reduction laser (a 585‐nm laser, Chromogenex V3; Chromogenex Light Technologies, Llanelli, U.K.) was developed, and there have already been several reports about its clinical effectiveness. The Chromogenex V3 laser has also been reported to be effective in treating acne and atopic dermatitis. These results suggest that the Chromogenex V3 laser has some immunological role. In this study, we investigated immunological changes elicited by laser irradiation at the ultrastructural level and by analysis of interleukin (IL)‐2 and IL‐4 mRNA in skin homing T lymphocytes. Materials and methods  Eight healthy adult volunteers (mean age 56·3 years, range 25–66 years) were recruited for this study. Ultrastructural analysis was done 3 h after the laser irradiation, as well as 1 day, 3 days, 1 week, 2 weeks, 4 weeks and 5 weeks later. IL‐2 and IL‐4 mRNAs in skin homing T cells cultured for 6 weeks were semiquantitatively measured using reverse transcriptase‐polymerase chain reaction. Results  Ultrastructural observations revealed that at 3 h after laser therapy, neutrophils, monocytes and mast cells could already be seen in the extravascular dermis. These dermal acute inflammatory changes were observed also at 1 week after laser treatment. Two weeks after laser treatment, the capillaries showed an almost normal structure. Four weeks after laser treatment, many lymphocytes and fibroblasts were observed. The numbers of these lymphocytes increased further at 5 weeks after the laser treatment. One week after the laser irradiation, all subjects were positive for IL‐2 mRNA and for IL‐4 mRNA. The level of IL‐4 mRNA was larger compared with that of IL‐2 mRNA in all subjects. Conclusion  The Chromogenex V3 is a 585‐nm visible light laser, and it may affect the skin not only by selective photothermolysis but also by direct cutaneous immunological activation.
Bibliography:istex:820580D6812DEA8F5B52C1C7221F4D346A0AAC4F
ark:/67375/WNG-3MS78QJL-P
ArticleID:BJD6971
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0007-0963
1365-2133
DOI:10.1111/j.1365-2133.2005.06971.x